Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate Cancer

Journal Article · · International Journal of Radiation Oncology, Biology and Physics
 [1]; ;  [2]; ;  [1];
  1. Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore (United States)
  2. Department of Radiation Oncology, Mayo Clinic, Rochester (United States)
Metastasis-directed therapy (MDT) is increasingly used in castration-sensitive oligometastatic prostate cancer because it prolongs progression-free survival (PFS) and androgen deprivation free survival. Here we describe patterns of recurrence and identify modes of progression after MDT using SABR.
OSTI ID:
23200889
Journal Information:
International Journal of Radiation Oncology, Biology and Physics, Journal Name: International Journal of Radiation Oncology, Biology and Physics Journal Issue: 2 Vol. 109; ISSN IOBPD3; ISSN 0360-3016
Country of Publication:
United States
Language:
English

Similar Records

Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer
Journal Article · Wed Jun 01 00:00:00 EDT 2016 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:22648686

Prognostic Value of [18F]-Fluoromethylcholine Positron Emission Tomography/Computed Tomography Before Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer
Journal Article · Fri Jun 15 00:00:00 EDT 2018 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:23065585

Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial
Journal Article · Thu Apr 15 00:00:00 EDT 2021 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:23200826